Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice

Cell Research

Volumn 24, Issue 9, 2014, Pages 1050-1066

  Chen, Jizheng ^a   Zhao, Yang ^b   Zhang, Chao ^b   Chen, Hairong ^b   Feng, Jin ^b   Chi, Xiumei ^c   Pan, Yu ^c   Du, Jun ^d   Guo, Min ^a   Cao, Huang ^a   Chen, Honghe ^a   Wang, Zilong ^a   Pei, Rongjuan ^a   Wang, Qian ^e   Pan, Lei ^b   Niu, Junqi ^c   Chen, Xinwen ^a   Tang, Hong ^a,b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d SHANXI UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

animal model; HCV; humanized mice; immune competent

Indexed keywords

INTERFERON;

ANIMAL; BLOOD; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOCOMPETENCE; INTERFERONS; LIVER; MALE; MICE, INBRED ICR; MICE, TRANSGENIC;

EID: 84906904698     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2014.116     Document Type: Article

References (55)

1. Thomas DL. Global control of hepatitis C: Where challenge meets opportunity. Nat Med 2013; 19:850-858
2. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008; 372:321-332
3. Chisari FV. Unscrambling hepatitis C virus-host interactions. Nature 2005; 436:930-932
4. Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature 2005; 436:933-938
5. Sklan EH, Charuworn P, Pang PS, Glenn JS. Mechanisms of HCV survival in the host. Nat Rev Gastroenterol Hepatol 2009; 6:217-227
6. Gale M, Jr, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005; 436:939-945
7. Bukh J. Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology 2012; 142:1279-1287
8. Walker CM. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer Semin Immunopathol 1997; 19:85-98
9. Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7:927-933
10. Bissig KD, Wieland SF, Tran P, et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 2010; 120:924-930
11. Washburn ML, Bility MT, Zhang L, et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011; 140:1334-1344
12. Dorner M, Horwitz JA, Robbins JB, et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011; 474:208-211
13. Dorner M, Horwitz JA, Donovan BM, et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 2013; 501:237-241
14. Han Q, Xu C, Wu C, Zhu W, Yang R, Chen X. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus research 2009; 145:63-73
15. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801
16. Lerat H, Berby F, Trabaud MA, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97:845-851
17. Krawczynski K, Beach MJ, Bradley DW, et al. Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identification. Gastroenterology 1992; 103:622-629
18. Sansonno D, Lauletta G, Dammacco F. Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay. J Viral Hepat 2004; 11:27-32
19. Liang Y, Shilagard T, Xiao SY, et al. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 2009; 137:1448-1458
20. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-626
21. Uprichard SL, Chung J, Chisari FV, Wakita T. Replication of a hepatitis C virus replicon clone in mouse cells. Virol J 2006; 3:89
22. Yasmin MY, Aziz B, Nazim M, Madhavan RK. Prealbumin rather than albumin is a more sensitive indicator of acute liver disease. Malays J Pathol 1993; 15:147-150
23. Kawamoto M, Mizuguchi T, Katsuramaki T, et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006; 12:4325-4330
24. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6:205-217
25. Brancatelli G, Federle MP, Ambrosini R, et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007; 61:57-69
26. Ito K, Mitchell DG, Gabata T, Hussain SM. Expanded gallbladder fossa: Simple MR imaging sign of cirrhosis. Radiology 1999; 211:723-726
27. Carithers RL, Jr, Sugano D, Bayliss M. Health assessment for chronic HCV infection: Results of quality of life. Dig Dis Sci 1996; 41:75S-80S.
28. Zhu Q, Guo JT, Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 2003; 77:9204-9210
29. McCaffrey AP, Ohashi K, Meuse L, et al. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Mol Ther 2002; 5:676-684
30. Long G, Hiet MS, Windisch MP, Lee JY, Lohmann V, Bartenschlager R. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Gastroenterology 2011; 141:1057-1066
31. Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 2013; 10:542-552
32. Horner SM, Gale M, Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 2013; 19:879-888
33. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-105
34. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472:481-485
35. Chang KS, Cai Z, Zhang C, Sen GC, Williams BR, Luo G. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: Protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. Journal of virology 2006; 80:7364-7374
36. Pflugheber J, Fredericksen B, Sumpter R, Jr, et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci USA 2002; 99:4650-4655
37. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999; 285:107-110
38. Chia R, Achilli F, Festing MF, Fisher EM. The origins and uses of mouse outbred stocks. Nat Genet 2005; 37:1181-1186
39. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM, Gale M Jr. Interferon regulatory factor-3 activation, hepatic interferon- stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology 2008; 47:799-809
40. Sugano M, Hayashi Y, Yoon S, et al. Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction. J Clin Pathol 1995; 48:820-825
41. Bigger CB, Guerra B, Brasky KM, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004; 78:13779-13792
42. Charpentier C, Champenois K, Gervais A, et al. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients. PloS One 2013; 8:e59205
43. Baden R, Rockstroh JK, Buti M. Natural history and management of hepatitis C: Does sex play a role? J Infect Dis 2014; 209 Suppl 3:S81-S85
44. Moreno M, Chaves JF, Sancho-Bru P, et al. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 2010; 51:974-985
45. Mekky RY, Abdelaziz AI. Sex hormones and HCV: An unresolved mystery. Expert Rev Gastroenterol Hepatol 2013; 7:69-75
46. van den Berg CH, Grady BP, Schinkel J, et al. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PloS One 2011; 6:e27555
47. Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR. Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology 2012; 56:1214-1222
48. Zhang Y, Weady P, Duggal R, Hao W. Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening. Antimicrob Agents Chemother 2008; 52:666-674
49. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102:9294-9299
50. Zhong J, Gastaminza P, Chung J, et al. Persistent hepatitis C virus infection in vitro: Coevolution of virus and host. J Virol 2006; 80:11082-11093
51. Zheng D, Chen G, Guo B, Cheng G, Tang H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res 2008; 18:1105-1113
52. Ittner LM, Gotz J. Pronuclear injection for the production of transgenic mice. Nat Protoc 2007; 2:1206-1215
53. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55:611-622
54. Watanabe H, Ohtsuka K, Kimura M, et al. Details of an isolation method for hepatic lymphocytes in mice. J Immunol Methods 1992; 146:145-154
55. Macias Rodriguez MA, Rendon Unceta P, Navas Relinque C, Tejada Cabrera M, Infantes Hernandez JM, Martin Herrera L. Ultrasonography in patients with chronic liver disease: Its usefulness in the diagnosis of cirrhosis. Rev Esp Enferm Dig 2003; 95:258-264